Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Follow-Up of Celiac Disease in Adults: "When, What, Who, and Where".
Mulder CJJ, Elli L, Lebwohl B, Makharia GK, Rostami K, Rubio-Tapia A, Schumann M, Tye-Din J, Zeitz J, Al-Toma A. Mulder CJJ, et al. Among authors: tye din j. Nutrients. 2023 Apr 24;15(9):2048. doi: 10.3390/nu15092048. Nutrients. 2023. PMID: 37432208 Free PMC article. Review.
Risk perception and knowledge of COVID-19 in patients with celiac disease.
Zhen J, Stefanolo JP, Temprano MP, Seiler CL, Caminero A, de-Madaria E, Huguet MM, Santiago V, Niveloni SI, Smecuol EG, Dominguez LU, Trucco E, Lopez V, Olano C, Mansueto P, Carroccio A, Green PH, Duerksen D, Day AS, Tye-Din JA, Bai JC, Ciacci C, Verdú EF, Lebwohl B, Pinto-Sanchez MI. Zhen J, et al. World J Gastroenterol. 2021 Mar 28;27(12):1213-1225. doi: 10.3748/wjg.v27.i12.1213. World J Gastroenterol. 2021. PMID: 33828395 Free PMC article.
Review article: Follow-up of coeliac disease.
Tye-Din JA. Tye-Din JA. Aliment Pharmacol Ther. 2022 Jul;56 Suppl 1(Suppl 1):S49-S63. doi: 10.1111/apt.16847. Aliment Pharmacol Ther. 2022. PMID: 35815829 Free PMC article. Review.
Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study.
Tye-Din JA, Daveson AJM, Goel G, Goldstein KE, Hand HL, Neff KM, Popp A, Taavela J, Maki M, Isola J, Williams LJ, Truitt KE, Anderson RP; RESET CeD Study Group. Tye-Din JA, et al. Lancet Gastroenterol Hepatol. 2023 May;8(5):446-457. doi: 10.1016/S2468-1253(22)00428-9. Epub 2023 Mar 7. Lancet Gastroenterol Hepatol. 2023. PMID: 36898393 Clinical Trial.
Stool Gluten Peptide Detection Is Superior to Urinary Analysis, Coeliac Serology, Dietary Adherence Scores and Symptoms in the Detection of Intermittent Gluten Exposure in Coeliac Disease: A Randomised, Placebo-Controlled, Low-Dose Gluten Challenge Study.
Russell AK, Lucas EC, Henneken LM, Pizzey CJ, Clarke D, Myleus A, Tye-Din JA. Russell AK, et al. Among authors: tye din ja. Nutrients. 2024 Jan 17;16(2):279. doi: 10.3390/nu16020279. Nutrients. 2024. PMID: 38257173 Free PMC article. Clinical Trial.
78 results